EXPEDITION-I: Efficacy and Safety of Glecaprevir/Pibrentasvir for Treatment of Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection in Adults with Compensated Cirrhosis

Press/Media: Press / Media

PeriodApr 21 2017

Media coverage

2

Media coverage

  • TitleEXPEDITION-I: Efficacy and Safety of Glecaprevir/Pibrentasvir for Treatment of Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection in Adults with Compensated Cirrhosis
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date4/21/17
    PersonsFred Poordad
  • TitleENDURANCE-3: SAFETY AND EFFICACY OF GLECAPREVIR/PIBRENTASVIR COMPARED TO SOFOSBUVIR PLUS DACLATASVIR IN TREATMENT-NAÏVE HCV GENOTYPE 3-INFECTED PATIENTS WITHOUT CIRRHOSIS
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date4/21/17
    PersonsFred Poordad